NCT/Study#
N/A /
TALQUETAMAB-OUTCOMES
Real World Outcomes of patients with Relapsed/ Refractory Multiple Myeloma on Talquetamab
DISEASE GROUP:
Multiple Myeloma
current phase:
N/A
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
